Alpha-interferon in chronic myelogenous leukaemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D016019:Survival Analysis
D000970:Antineoplastic Agents; D016898:Interferon-alpha